首页 > 最新文献

Current Infectious Disease Reports最新文献

英文 中文
What is New in Augmented Renal Clearance in Septic Patients? 脓毒症患者增强肾清除率有什么新进展?
4区 医学 Q1 Medicine Pub Date : 2023-10-26 DOI: 10.1007/s11908-023-00816-6
Laura Baptista, Inês Moura, Catarina Mendes Silva, João Pedro Baptista
Abstract Purpose of Review In this narrative review encompassing relevant scientific publications regarding critically ill patients in the last 5 years, we discuss key questions regarding the concept, pathophysiology, identification, epidemiology, and implications of augmented renal clearance (ARC) in the treatment of sepsis. Recent Findings Mathematical estimates of renal function show low accuracy when evaluating renal function in the intensive care unit, jeopardizing the correct dosing of antimicrobials. The description of ARC in critically ill patients in several, distant geographical areas worldwide reveals that this condition is more frequent than anticipated. Several new risk factors have been recently reported, needing future confirmation. Pathophysiology is still largely unknown; however, intact kidney physiology, inflammatory mediators, and tubular secretion seem to play a role. Several studies have demonstrated the association between ARC and subtherapeutic levels of several β-lactams, vancomycin, and fluconazole. Lately, there have been recommendations of dosage regimen adjustments for patients with ARC, namely, through increases in total daily dose or prolonged infusion for various antimicrobials. Literature is scarce describing the influence of ARC on clinical outcomes of patients receiving antibiotics, and results are contradictory. Summary Growing body of evidence supports that measured creatinine clearance based on time-defined urine output is strongly recommended for the identification of ARC and for reliable evaluation of its prevalence and risk factors. Clinicians should be alert for the need to use off-label dosing of antimicrobials in septic patients showing ARC. Concise recommendations for antibiotic dosage regimens, based on clinical data, are still needed.
摘要:本文综述了近5年来危重症患者的相关科学文献,讨论了增强肾清除率(ARC)在脓毒症治疗中的概念、病理生理学、鉴定、流行病学和意义等关键问题。在重症监护病房评估肾功能时,肾功能的数学估计显示准确性较低,危及抗微生物药物的正确剂量。在世界上几个遥远的地理区域对危重患者中ARC的描述表明,这种情况比预期的更为频繁。最近报道了几个新的危险因素,需要进一步确认。病理生理学在很大程度上仍然未知;然而,完整的肾脏生理、炎症介质和肾小管分泌似乎发挥了作用。一些研究已经证明了ARC与几种β-内酰胺、万古霉素和氟康唑的亚治疗水平之间的关联。最近,有人建议调整ARC患者的给药方案,即增加每日总剂量或延长各种抗菌素的输注时间。文献很少描述ARC对抗生素患者临床结局的影响,结果也相互矛盾。越来越多的证据支持,强烈建议基于时间定义的尿量测量肌酐清除率,以确定ARC,并可靠地评估其患病率和危险因素。临床医生应该警惕在出现ARC的脓毒症患者中使用超说明书剂量的抗菌剂的必要性。仍然需要根据临床数据对抗生素剂量方案提出简明的建议。
{"title":"What is New in Augmented Renal Clearance in Septic Patients?","authors":"Laura Baptista, Inês Moura, Catarina Mendes Silva, João Pedro Baptista","doi":"10.1007/s11908-023-00816-6","DOIUrl":"https://doi.org/10.1007/s11908-023-00816-6","url":null,"abstract":"Abstract Purpose of Review In this narrative review encompassing relevant scientific publications regarding critically ill patients in the last 5 years, we discuss key questions regarding the concept, pathophysiology, identification, epidemiology, and implications of augmented renal clearance (ARC) in the treatment of sepsis. Recent Findings Mathematical estimates of renal function show low accuracy when evaluating renal function in the intensive care unit, jeopardizing the correct dosing of antimicrobials. The description of ARC in critically ill patients in several, distant geographical areas worldwide reveals that this condition is more frequent than anticipated. Several new risk factors have been recently reported, needing future confirmation. Pathophysiology is still largely unknown; however, intact kidney physiology, inflammatory mediators, and tubular secretion seem to play a role. Several studies have demonstrated the association between ARC and subtherapeutic levels of several β-lactams, vancomycin, and fluconazole. Lately, there have been recommendations of dosage regimen adjustments for patients with ARC, namely, through increases in total daily dose or prolonged infusion for various antimicrobials. Literature is scarce describing the influence of ARC on clinical outcomes of patients receiving antibiotics, and results are contradictory. Summary Growing body of evidence supports that measured creatinine clearance based on time-defined urine output is strongly recommended for the identification of ARC and for reliable evaluation of its prevalence and risk factors. Clinicians should be alert for the need to use off-label dosing of antimicrobials in septic patients showing ARC. Concise recommendations for antibiotic dosage regimens, based on clinical data, are still needed.","PeriodicalId":48839,"journal":{"name":"Current Infectious Disease Reports","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134909304","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Infection Prevention in Remote or Resource-Limited Settings: Deploying Technology While Preserving the Human Touch 在远程或资源有限的环境中预防感染:在保持人性化的同时部署技术
4区 医学 Q1 Medicine Pub Date : 2023-10-24 DOI: 10.1007/s11908-023-00814-8
Rachel Pryor, Yashasvisai Veeramasu, Gonzalo Bearman
{"title":"Infection Prevention in Remote or Resource-Limited Settings: Deploying Technology While Preserving the Human Touch","authors":"Rachel Pryor, Yashasvisai Veeramasu, Gonzalo Bearman","doi":"10.1007/s11908-023-00814-8","DOIUrl":"https://doi.org/10.1007/s11908-023-00814-8","url":null,"abstract":"","PeriodicalId":48839,"journal":{"name":"Current Infectious Disease Reports","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135273709","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Challenges Facing PICUs in Low- and Middle-Income Countries in the Treatment of Emerging Multidrug-Resistant Organisms: a Review and Perspective from a South African PICU 低收入和中等收入国家PICU在治疗新出现的多重耐药菌方面面临的挑战:来自南非PICU的回顾和观点
4区 医学 Q1 Medicine Pub Date : 2023-10-14 DOI: 10.1007/s11908-023-00817-5
Robin T. Saggers, Lesego M. Mothibi, Adam D. Irwin, Kuban D. Naidoo
Abstract Purpose of Review Antimicrobial resistance continues to increase throughout the world, with the impact on critically ill children in low- and middle-income paediatric intensive care units largely unknown. Recent Findings There has been a global shift indicating a predominance of Gram-negative bacilli among multidrug-resistant isolates. A 4-year review (2019 to 2022) found a progressive and substantial increase in the incidence of carbapenem-resistant Klebsiella pneumoniae (29% to 51%) alongside high levels of carbapenem-resistant Acinetobacter baumannii (93%) within the paediatric intensive care unit at the Chris Hani Baragwanath Academic Hospital in South Africa. The pharmacological treatment of these infections relies heavily on the continued use of carbapenems, often in combination with colistin. Summary The burden of antimicrobial resistance is disproportionately borne, particularly within sub-Saharan Africa and South Asia. The resource-constrained South African public healthcare system, already significantly burdened by both HIV and TB, continues to face several challenges in combating the growth in antimicrobial resistance. Limited access, largely driven by prohibitive costs, to sophisticated laboratory techniques and newer pharmacological agents, leaves the implementation of effective infection prevention and control and antimicrobial stewardship programmes as the most pragmatic options to address the problem.
世界各地的抗菌素耐药性持续增加,对低收入和中等收入儿科重症监护病房的重症儿童的影响在很大程度上尚不清楚。最近的发现有一个全球性的转变,表明革兰氏阴性杆菌在耐多药分离株中占主导地位。一项为期4年的回顾(2019年至2022年)发现,在南非Chris Hani Baragwanath学术医院的儿科重症监护室中,耐碳青霉烯肺炎克雷伯菌的发病率(29%至51%)不断大幅增加,同时耐碳青霉烯鲍曼不动杆菌的发病率也很高(93%)。这些感染的药物治疗在很大程度上依赖于碳青霉烯类药物的持续使用,通常与粘菌素联合使用。抗菌素耐药性的负担是不成比例的,特别是在撒哈拉以南非洲和南亚。资源有限的南非公共卫生系统已经受到艾滋病毒和结核病的严重负担,在应对抗菌素耐药性增长方面继续面临若干挑战。主要由于高昂的费用,复杂的实验室技术和较新的药理学制剂的获取有限,因此实施有效的感染预防和控制以及抗微生物药物管理规划是解决这一问题的最务实选择。
{"title":"Challenges Facing PICUs in Low- and Middle-Income Countries in the Treatment of Emerging Multidrug-Resistant Organisms: a Review and Perspective from a South African PICU","authors":"Robin T. Saggers, Lesego M. Mothibi, Adam D. Irwin, Kuban D. Naidoo","doi":"10.1007/s11908-023-00817-5","DOIUrl":"https://doi.org/10.1007/s11908-023-00817-5","url":null,"abstract":"Abstract Purpose of Review Antimicrobial resistance continues to increase throughout the world, with the impact on critically ill children in low- and middle-income paediatric intensive care units largely unknown. Recent Findings There has been a global shift indicating a predominance of Gram-negative bacilli among multidrug-resistant isolates. A 4-year review (2019 to 2022) found a progressive and substantial increase in the incidence of carbapenem-resistant Klebsiella pneumoniae (29% to 51%) alongside high levels of carbapenem-resistant Acinetobacter baumannii (93%) within the paediatric intensive care unit at the Chris Hani Baragwanath Academic Hospital in South Africa. The pharmacological treatment of these infections relies heavily on the continued use of carbapenems, often in combination with colistin. Summary The burden of antimicrobial resistance is disproportionately borne, particularly within sub-Saharan Africa and South Asia. The resource-constrained South African public healthcare system, already significantly burdened by both HIV and TB, continues to face several challenges in combating the growth in antimicrobial resistance. Limited access, largely driven by prohibitive costs, to sophisticated laboratory techniques and newer pharmacological agents, leaves the implementation of effective infection prevention and control and antimicrobial stewardship programmes as the most pragmatic options to address the problem.","PeriodicalId":48839,"journal":{"name":"Current Infectious Disease Reports","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135802074","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploiting Electronic Data to Advance Knowledge and Management of Severe Infections 利用电子数据提高对严重感染的认识和管理
4区 医学 Q1 Medicine Pub Date : 2023-10-11 DOI: 10.1007/s11908-023-00815-7
Kevin B. Laupland, Alexis Tabah, Kyle C. White, Mahesh Ramanan
Abstract Purpose of Review To identify opportunities and recent advances in the use of multicentric digital data sources and networks to investigate the epidemiology and management of patients with infections admitted to intensive care units (ICUs). Recent Findings Electronic surveillance systems for a range of serious infections have been reported from large cohorts with evident improvements in efficiency, objectivity, and comprehensiveness of coverage as compared to traditional methods. Electronic data, most notably from electronic health records, has been used to define the epidemiology and outcomes of severe infections in several settings and conditions and has facilitated population-based evaluation. Automated alerts and notifications hold promise to identify patients at risk for sepsis and bloodstream infection although demonstration of efficacy in interventional trials is needed. Summary Exploitation of electronic data in ICUs has led to a better understanding of the epidemiology of severe infections and holds promise for future interventional clinical trials.
摘要:综述的目的:探讨利用多中心数字数据源和网络来调查重症监护病房(icu)感染患者的流行病学和管理的机会和最新进展。与传统方法相比,电子监测系统在效率、客观性和覆盖范围的全面性方面有了明显的提高。电子数据,尤其是来自电子健康记录的数据,已被用于确定几种环境和条件下严重感染的流行病学和结果,并促进了基于人口的评估。自动警报和通知有望识别有败血症和血液感染风险的患者,尽管需要在干预性试验中证明其有效性。icu中电子数据的利用使人们更好地了解严重感染的流行病学,并为未来的介入性临床试验带来希望。
{"title":"Exploiting Electronic Data to Advance Knowledge and Management of Severe Infections","authors":"Kevin B. Laupland, Alexis Tabah, Kyle C. White, Mahesh Ramanan","doi":"10.1007/s11908-023-00815-7","DOIUrl":"https://doi.org/10.1007/s11908-023-00815-7","url":null,"abstract":"Abstract Purpose of Review To identify opportunities and recent advances in the use of multicentric digital data sources and networks to investigate the epidemiology and management of patients with infections admitted to intensive care units (ICUs). Recent Findings Electronic surveillance systems for a range of serious infections have been reported from large cohorts with evident improvements in efficiency, objectivity, and comprehensiveness of coverage as compared to traditional methods. Electronic data, most notably from electronic health records, has been used to define the epidemiology and outcomes of severe infections in several settings and conditions and has facilitated population-based evaluation. Automated alerts and notifications hold promise to identify patients at risk for sepsis and bloodstream infection although demonstration of efficacy in interventional trials is needed. Summary Exploitation of electronic data in ICUs has led to a better understanding of the epidemiology of severe infections and holds promise for future interventional clinical trials.","PeriodicalId":48839,"journal":{"name":"Current Infectious Disease Reports","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136210687","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Monkeypox 2022 vs. COVID-19: a Review on a National Health Emergency with Emphasis on Cutaneous Manifestations 猴痘2022与COVID-19:对国家突发卫生事件的回顾,重点是皮肤表现
4区 医学 Q1 Medicine Pub Date : 2023-09-18 DOI: 10.1007/s11908-023-00813-9
Mohammad Rezaei Zadeh Rukerd, Pouria Pourzand, Nasir Arefinia, Davood Bashash, Amin Sayyadi, Mohsen Nakhaie, Simin Shamsi Meymandi
{"title":"Monkeypox 2022 vs. COVID-19: a Review on a National Health Emergency with Emphasis on Cutaneous Manifestations","authors":"Mohammad Rezaei Zadeh Rukerd, Pouria Pourzand, Nasir Arefinia, Davood Bashash, Amin Sayyadi, Mohsen Nakhaie, Simin Shamsi Meymandi","doi":"10.1007/s11908-023-00813-9","DOIUrl":"https://doi.org/10.1007/s11908-023-00813-9","url":null,"abstract":"","PeriodicalId":48839,"journal":{"name":"Current Infectious Disease Reports","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135153748","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mpox in 2023: Current Epidemiology and Management Mpox在2023年:当前流行病学和管理
IF 3.1 4区 医学 Q1 Medicine Pub Date : 2023-09-02 DOI: 10.1007/s11908-023-00812-w
S. Barkati, Luke B. Harrison, Marina B. Klein, Francesca F. Norman
{"title":"Mpox in 2023: Current Epidemiology and Management","authors":"S. Barkati, Luke B. Harrison, Marina B. Klein, Francesca F. Norman","doi":"10.1007/s11908-023-00812-w","DOIUrl":"https://doi.org/10.1007/s11908-023-00812-w","url":null,"abstract":"","PeriodicalId":48839,"journal":{"name":"Current Infectious Disease Reports","volume":null,"pages":null},"PeriodicalIF":3.1,"publicationDate":"2023-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47028292","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ebola and Marburg Virus Infections in Resource-Rich Countries: Implications for Future Outbreaks 资源丰富国家的埃博拉和马尔堡病毒感染:对未来疫情的影响
IF 3.1 4区 医学 Q1 Medicine Pub Date : 2023-08-30 DOI: 10.1007/s11908-023-00810-y
E. Meltzer, Eli Schwartz
{"title":"Ebola and Marburg Virus Infections in Resource-Rich Countries: Implications for Future Outbreaks","authors":"E. Meltzer, Eli Schwartz","doi":"10.1007/s11908-023-00810-y","DOIUrl":"https://doi.org/10.1007/s11908-023-00810-y","url":null,"abstract":"","PeriodicalId":48839,"journal":{"name":"Current Infectious Disease Reports","volume":null,"pages":null},"PeriodicalIF":3.1,"publicationDate":"2023-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42345326","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
New Vaccines on the Immediate Horizon for Travelers: Chikungunya and Dengue Vaccines 旅行者眼前的新疫苗:基孔肯雅和登革热疫苗
IF 3.1 4区 医学 Q1 Medicine Pub Date : 2023-08-23 DOI: 10.1007/s11908-023-00811-x
Sonia Menon, A. Wilder-Smith
{"title":"New Vaccines on the Immediate Horizon for Travelers: Chikungunya and Dengue Vaccines","authors":"Sonia Menon, A. Wilder-Smith","doi":"10.1007/s11908-023-00811-x","DOIUrl":"https://doi.org/10.1007/s11908-023-00811-x","url":null,"abstract":"","PeriodicalId":48839,"journal":{"name":"Current Infectious Disease Reports","volume":null,"pages":null},"PeriodicalIF":3.1,"publicationDate":"2023-08-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41837260","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Airport COVID-19 Testing of Travelers: An Island Destination Perspective 机场旅客COVID-19检测:岛屿目的地视角
IF 3.1 4区 医学 Q1 Medicine Pub Date : 2023-07-03 DOI: 10.1007/s11908-023-00809-5
A. Hou, G. Pang, K. Mills, K. Bayudan, Danielle M. Moore, L. P. Medina, Lorrin W. Pang
{"title":"Airport COVID-19 Testing of Travelers: An Island Destination Perspective","authors":"A. Hou, G. Pang, K. Mills, K. Bayudan, Danielle M. Moore, L. P. Medina, Lorrin W. Pang","doi":"10.1007/s11908-023-00809-5","DOIUrl":"https://doi.org/10.1007/s11908-023-00809-5","url":null,"abstract":"","PeriodicalId":48839,"journal":{"name":"Current Infectious Disease Reports","volume":null,"pages":null},"PeriodicalIF":3.1,"publicationDate":"2023-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46845776","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence and Resistance Patterns of Streptococcus pneumoniae Recovered from Children in Western Asia 西亚儿童肺炎链球菌的患病率和耐药性
IF 3.1 4区 医学 Q1 Medicine Pub Date : 2023-07-03 DOI: 10.1007/s11908-023-00807-7
Y. M. Matran, A. Al-Haddad, D. Sharma, N. Kalia, Saurabh Sharma, Manoj Kumar, Sandeep Sharma
{"title":"Prevalence and Resistance Patterns of Streptococcus pneumoniae Recovered from Children in Western Asia","authors":"Y. M. Matran, A. Al-Haddad, D. Sharma, N. Kalia, Saurabh Sharma, Manoj Kumar, Sandeep Sharma","doi":"10.1007/s11908-023-00807-7","DOIUrl":"https://doi.org/10.1007/s11908-023-00807-7","url":null,"abstract":"","PeriodicalId":48839,"journal":{"name":"Current Infectious Disease Reports","volume":null,"pages":null},"PeriodicalIF":3.1,"publicationDate":"2023-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48480483","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Current Infectious Disease Reports
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1